-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
3-Chloro-6-(4-piperidyloxy)pyridazine is a compound that has gained significant attention in recent years due to its potential use as an anti-inflammatory and anti-cancer agent.
The chemical structure of 3-chloro-6-(4-piperidyloxy)pyridazine consists of a six-membered pyridazine ring, which is substituted with a chlorine atom and a piperidine-derived moiety.
Despite its potential use as a pharmaceutical agent, the synthesis of 3-chloro-6-(4-piperidyloxy)pyridazine has remained a challenging task for organic chemists.
There are several methods available in the literature for the synthesis of 3-chloro-6-(4-piperidyloxy)pyridazine, including traditional synthetic routes and more recent, cutting-edge methods.
One of the most common methods for the synthesis of this compound involves the reaction of 6-bromo-3-chloropyridazine-2,4-dione with 2-(4-piperidyloxy)ethanol in the presence of a base such as sodium carbonate.
This reaction is followed by treatment with a reducing agent such as lithium aluminum hydride to reduce the nitro group to the corresponding amine.
Finally, the compound is dechlorinated using a reagent such as thiophenol to yield the desired product.
Another method for the synthesis of 3-chloro-6-(4-piperidyloxy)pyridazine involves the use of a Pd/C catalyst for the reduction of 6-bromo-3-chloropyridazine-2,4-dione to the corresponding amine, followed by treatment with 2-(4-piperidyloxy)ethanol in the presence of a base such as sodium hydroxide.
This method has the advantage of avoiding the need for a reducing agent such as lithium aluminum hydride, which can be hazardous and expensive to handle.
Recently, researchers have developed new, more efficient synthetic routes for 3-chloro-6-(4-piperidyloxy)pyridazine using modern synthetic methods.
One such method involves the use of a metal-organic framework (MOF) as a catalyst for the reduction of 6-bromo-3-chloropyridazine-2,4-dione to the corresponding amine.
This method has the advantage of providing a recyclable, heterogeneous catalyst that can be easily separated from the reaction mixture, allowing for a more efficient and cost-effective synthesis.
Another recent development in the synthesis of 3-chloro-6-(4-piperidyloxy)pyridazine involves the use of microwave irradiation as a means of accelerating the reaction.
This method has been shown to provide improved yields and reduced reaction times compared to traditional synthetic routes, making it a highly attractive option for synthesizing this compound on a large scale.
Overall, the synthesis of 3-chloro-6-(4-piperidyloxy)pyridazine has been a challenging task for organic chemists, but recent developments in synthetic methodology have provided new, more efficient routes for its synthesis.
These methods offer improved yields, reduced reaction times, and greater cost-effectiveness, making them highly attractive for the synthesis of this compound on a commercial scale.
As research in this area continues, it is likely that even more efficient and cost-effective methods will be developed, making 3-chloro-6-(4-piperidyloxy)pyridazine an even more accessible and valuable compound for use as a pharmaceutical agent.